Evidence for pharmacological interventions to reduce cardiovascular risk for patients with chronic kidney disease: a study protocol of an evidence map

BACKGROUND: Patients with chronic kidney disease (CKD) require a personalised strategy for cardiovascular risk management (CVRM) to reduce their high risk of cardiovascular morbidity and mortality. Despite their high risk, patients with CKD appear to be underrepresented in randomised controlled tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombijn, Julia M. T., Idema, Demy L., van der Braak, Kim, Spijker, Rene, Meijvis, Sabine C. A., Bots, Michiel L., Hooft, Lotty, Verhaar, Marianne C., Vernooij, Robin W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655868/
https://www.ncbi.nlm.nih.gov/pubmed/36371302
http://dx.doi.org/10.1186/s13643-022-02108-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655868/
https://www.ncbi.nlm.nih.gov/pubmed/36371302
http://dx.doi.org/10.1186/s13643-022-02108-x

Ejemplares similares